Literature DB >> 12160136

Epithelial differentiation and proliferative potential in spinal ependymomas.

Hiroaki Takeuchi1, Toshihiko Kubota, Kazufumi Sato, Josefina F Llena, Asao Hirano.   

Abstract

The aim of this investigation was recognition of the epithelial differentiation and proliferative activity of ependymomas in the spinal cord compared with astrocytomas in the spinal cord and ependymoma in the brain. We investigated histopathological and immunohistochemical examination in thirty-five cases, including eleven ependymomas, thirteen astrocytomas in the spinal region and eleven ependymomas in the intracranial region. An anti-epithelial membrane antigen antibody (EMA), and two types of anti-cytokeratin antibodies, CAM 5.2 (45 and 52 kDa) and keratin (56 and 64 kDa) were applied as epithelial markers. The proliferative potential of the tumors was investigated using the Ki-67 labeling index (LI, %). Histologically, perivascular pseudorosettes were seen in all of the spinal and intracranial ependymomas. There were few ependymal structures in the spinal ependymomas except in the myxopapillary type. Immunohistochemical study demonstrated that nine (82%) were immunoreactive for EMA, eight (73%) were immunoreactive for CAM 5.2 and three (27%) were immunoreactive for keratin in the spinal ependymomas. In the spinal astrocytomas, no tumors were immunoreactive for EMA or CAM 5.2. One of thirteen cases was immunoreactive for keratin. The Ki-67 LI of the spinal ependymomas was lower than that of the intracranial ependymoma (p < 0.01). Epithelial differentiation was found in the ependymomas which may reflect the differences in histological and biological features between ependymomas and astrocytomas in the spinal cord. Regional differences in ependymomas may influence not only clinical features but also histo-pathological characteristics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12160136     DOI: 10.1023/a:1015844704632

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  15 in total

1.  Ependymoma: a follow-up study of 101 cases.

Authors:  S J Mork; A C Loken
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

2.  Ependymal and choroid plexus tumors. Cytokeratin and GFAP expression.

Authors:  H Mannoji; L E Becker
Journal:  Cancer       Date:  1988-04-01       Impact factor: 6.860

3.  Ependymomas--an immunohistochemical study of 14 cases.

Authors:  H K Ng; C C Tse; S T Lo
Journal:  Histopathology       Date:  1988-10       Impact factor: 5.087

4.  Abnormal cilia in a malignant ependymoma.

Authors:  T Kubota; J Ishise; T Yamashima; S Yamamoto
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

5.  The fine structure of ependymoblastoma.

Authors:  A Hirano; N R Ghatak; H M Zimmerman
Journal:  J Neuropathol Exp Neurol       Date:  1973-01       Impact factor: 3.685

6.  Ultrastructure of human and experimental ependymomas. A comparative study.

Authors:  H H Goebel; H Cravioto
Journal:  J Neuropathol Exp Neurol       Date:  1972-01       Impact factor: 3.685

7.  Subepithelial basement membrane deposition and intermediate filament expression in choroid plexus neoplasms and ependymomas.

Authors:  P N Furness; J Lowe; G S Tarrant
Journal:  Histopathology       Date:  1990-03       Impact factor: 5.087

8.  Adult intramedullary spinal cord ependymomas: the result of surgery in 38 patients.

Authors:  F J Epstein; J P Farmer; D Freed
Journal:  J Neurosurg       Date:  1993-08       Impact factor: 5.115

9.  Immunohistological diagnosis of central nervous system tumours using a monoclonal antibody panel.

Authors:  H B Coakham; J A Garson; P M Allan; E I Harper; B Brownell; J T Kemshead; E B Lane
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

10.  Intracytoplasmic lumina in ependymomas: an ultrastructural study.

Authors:  K L Ho; D V Caccamo; J H Garcia
Journal:  Ultrastruct Pathol       Date:  1994 May-Jun       Impact factor: 1.094

View more
  3 in total

Review 1.  Immunohistochemical prognostic markers in intracranial ependymomas: systematic review and meta-analysis.

Authors:  Klara Kuncova; Ales Janda; Pavel Kasal; Josef Zamecnik
Journal:  Pathol Oncol Res       Date:  2009-03-20       Impact factor: 3.201

2.  Immunohistochemical study of CD99 and EMA expression in ependymomas.

Authors:  Soheir Mahfouz; Ahmad Abdel Aziz; Samia M Gabal; Samar el-Sheikh
Journal:  Medscape J Med       Date:  2008-02-19

3.  Seven kinds of intermediate filament networks in the cytoplasm of polarized cells: structure and function.

Authors:  Hirohiko Iwatsuki; Masumi Suda
Journal:  Acta Histochem Cytochem       Date:  2010-04-21       Impact factor: 1.938

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.